Jundishapur Scientific Medical Journal

Jundishapur Scientific Medical Journal

Oral Complications in Patients Receiving Radiotherapy in the Head and Neck Region with or without Chemotherapy Refering to Milad Hospital from 2020-2021

Document Type : Original Article

Authors
1 Dental Research Center, Department of Oral and Maxillofacial Pathology, Dental Research Institute, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran.
2 Isfahan Milad Hospital , Deputy Manager in Research & Education, Head, Department of Radiation Oncology , Isfaha,Iran
3 Department of Oral and Maxillofacial Pathology ,Students Research Committee, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran
4 Department of Oral and Maxillofacial Pathology ,Students Research Committee, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran orcid: 0000-0003-0029-3045
5 Department of Oral and Maxillofacial Pathology ,Students Research Committee, School of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran.
10.32592/JSMJ.23.4.313
Abstract
Background and Objectives Oral complications can significantly impact not only the treatment process of patients undergoing chemotherapy and radiotherapy but also their overall quality of life. This study aimed to evaluate the frequency of oral complications in patients undergoing radiotherapy with or without chemotherapy in Milad Hospital of Isfahan in 2020-2021.
Subjects and Methods This descriptive and analytical study was conducted on 43 patients diagnosed with cancer who were admitted to the chemotherapy and radiotherapy department at Milad Hospital. Two dental students examined the patients for oral lesions and complications. The data were recorded in SPSS and analyzed using Spearman's correlation, Fisher's exact test, Mann-Whitney U test, Kruskal-Wallis test, and the t-test (p-value < 0.05).
Results Among the 43 patients, the most common oral lesions included mucositis, xerostomia, taste dysfunction and dysphasia. Statistically significant correlations were found between mucosal hemorrhage and cancer site, oropharyngeal ulcer and average radiotherapy dose, mucositis grade and average radiotherapy dose, xerostomia and average radiotherapy dose, and nausea and average radiotherapy dose. However, no significant relationships were observed between other factors and the study variables.
Conclusion The intensity of some complications caused by radiotherapy on oral mucosa, including mucositis, xerostomia, oropharynx ulcer and neusa in patients, increased with higher radiations doses. Therefore, clinicians can potentially manage oral complications more effectively by implementing various strategies, including carefully controlling radiotherapy doses and providing comprehensive oral hygiene education to patien               
Keywords
Subjects

  •  

    • Ghantous Y, Elnaaj A. Global incidence and risk factors of oral cancer. Harefuah. 2017 Oct 1;156(10):645-9. [PMID]
    • Gandhi K, Datta G, Ahuja S, Saxena T, Datta AG. Prevalence of oral complications occurring in a population of pediatric cancer patients receiving chemotherapy. International journal of clinical pediatric dentistry. 2017 Apr;10(2):166. [5005/iD-iournals-10005-1428 ] [PMID]
    • Eshghyar N, Bateby M. The prevalence of chemotherapy side effects of cancerous patients on oral health. J Dent Med. 2001 Aug 10;14(2):32-7.
    • Epstein JB, Stevenson-Moore P. Periodontal disease and periodontal management in patients with cancer. Oral oncology. 2001 Dec 1;37(8):613-9. [1016/s1368-8375(01)00025-2 ] [PMID]
    • Bhandari S, Soni BW, Bahl A, Ghoshal S. Radiotherapy‐induced oral morbidities in head and neck cancer patients. Special Care in Dentistry. 2020 May;40(3):238-50. [1111/scd.12469 ] [PMID]
    • Buttiron Webber T, Briata IM, DeCensi A, Cevasco I, Paleari L. Taste and smell disorders in cancer treatment: results from an integrative rapid systematic review. International Journal of Molecular Sciences. 2023 Jan 28;24(3):2538. [3390/ijms24032538 ] [PMID]
    • van der Putten GJ, Brand HS, Schols JM, de Baat C. The diagnostic suitability of a xerostomia questionnaire and the association between xerostomia, hyposalivation and medication use in a group of nursing home residents. Clinical oral investigations. 2011 Apr;15:185-92. [1007/s00784-010-0382-1 ] [PMID]
    • Neville BW, Damm DD, Allen CM, Bouqout JE. Oral and Maxillofacial Pathology. 4th ed. Philadelphia: WB Saunders Co; 2023. p. 201-212.
    •  Ahadian H, Yassaei S, Bouzarjomehri F, Targhi MG, Kheirollahi K. Oral complications of the oromaxillofacial area radiotherapy. Asian Pacific journal of cancer prevention: APJCP. 2017;18(3):721. [22034/APJCP.2017.18.3.721 ] [PMID]
    • Martinez AC, Silva IM, Couto SA, Gandra RF, Rosa EA, Johann AC, Souza PH. Late oral complications caused by head and neck radiotherapy: clinical and laboratory study. Journal of Oral & Maxillofacial Research. 2020 Jul;11(3). [5037/jomr.2020.11303 ] [PMID]
    • García-Chías B, Figuero E, Castelo-Fernández B, Cebrián-Carretero JL, Cerero-Lapiedra R. Prevalence of oral side effects of chemotherapy and its relationship with periodontal risk: a cross sectional study. Supportive Care in Cancer. 2019 Sep 1;27:3479-90. [1007/s00520-019-4650-6 ] [PMID]
    • Lopez Silva CP, Wei Ting MA, Sundaresan PD, Borromeo G. Oral management of patients with cancer. Revista Facultad de Odontología Universidad de Antioquia. 2019 Dec;31(1):178-97.
    • Pulito C, Cristaudo A, Porta CL, Zapperi S, Blandino G, Morrone A, Strano S. Oral mucositis: the hidden side of cancer therapy. Journal of experimental & clinical cancer research. 2020 Dec;39:1-5. [1186/s13046-020-01715-7 ] [PMID]
    • Drareni K, Dougkas A, Giboreau A, Laville M, Souquet PJ, Bensafi M. Relationship between food behavior and taste and smell alterations in cancer patients undergoing chemotherapy: A structured review. InSeminars in oncology 2019 Apr 1 (Vol. 46, No. 2, pp. 160-172). WB Saunders. [1053/j.seminoncol.2019.05.002 ] [PMID]
    • Dehabadi F, Badiee Z, Parisay I. The prevalence of oral mucositis caused by chemotherapy and its risk factors in children with cancer who were referred to hematology and oncology wards of Doctor Sheikh Hospital in 2014. Medical journal of mashhad university of medical sciences. 2016 Jan 21;58(10):578-89.
    • Rabiei M, Rahimi A, Jalalian B. Complication of post radiation in patients with head and neck cancer. Journal of Gorgan University of Medical Sciences. 2014 Jul 10;16(2):114-20.
    • Worthington HV, Clarkson JE, Bryan G, Furness S, Glenny AM, Littlewood A, McCabe MG, Meyer S, Khalid T, Riley P. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane database of systematic reviews. 2011(4). [1002/14651858.CD000978.pub5 ] [PMID]
    • Ranta P, Kytö E, Nissi L, Kinnunen I, Vahlberg T, Minn H, Haapio E, Nelimarkka L, Irjala H. Dysphagia, hypothyroidism, and osteoradionecrosis after radiation therapy for head and neck cancer. Laryngoscope Investigative Otolaryngology. 2022 Feb;7(1):108-16.. [1002/lio2.711 ] [PMID]
    • Faustino IS, Georgaki M, Santos-Silva AR, Vargas PA, Lopes MA. Head and neck radiotherapy leading to extensive late oral soft-tissue necrosis. Oral oncology. 2022 Feb 1;125:105710. [1016/j.oraloncology.2021.105710 ] [PMID]
    • Gu F, Farrugia MK, Duncan WD, Feng Y, Hutson AD, Schlecht NF, Repasky EA, Antoch MP, Miller A, Platek A, Platek ME. Daily time of radiation treatment is associated with subsequent oral mucositis severity during radiotherapy in head and neck cancer patients. Cancer Epidemiology, Biomarkers & Prevention. 2020 May 1;29(5): 949-55. [1158/1055-9965.EPI-19-0961 ] [PMID]
    • Vasiliadou I, Noble D, Hartley A, Moleron R, Sanghera P, Urbano TG, Schipani S, Gujral D, Foran B, Bhide S, Haridass A. A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic. Clinical and Translational Radiation Oncology. 2021 Sep 1;30:50-9. [1016/j.ctro.2021.06.002 ] [PMID]
Volume 23, Issue 4 - Serial Number 151
September and October 2024
Pages 313-322

  • Receive Date 08 April 2024
  • Revise Date 13 June 2024
  • Accept Date 16 June 2024